0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Uterine Fibroid Embolization Device Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-2T11927
Home | Market Reports | Health| Reproductive Health
Global Uterine Fibroid Embolization Device Market Research Report 2022
BUY CHAPTERS

Global Uterine Fibroid Embolization Device Market Research Report 2024

Code: QYRE-Auto-2T11927
Report
April 2024
Pages:101
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Uterine Fibroid Embolization Device Market

The global Uterine Fibroid Embolization Device market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Uterine Fibroid Embolization Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Uterine Fibroid Embolization Device is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Uterine Fibroid Embolization Device include Boston Scientific Corporation, Merit Medical Systems, BioSpace, Hologic, Inc., Cook Medical, Ferring B.V., Smith+Nephew, CooperSurgical, Inc. and Aetna Better Health of Pennsylvania, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Uterine Fibroid Embolization Device, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Uterine Fibroid Embolization Device.

Report Scope

The Uterine Fibroid Embolization Device market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Uterine Fibroid Embolization Device market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Uterine Fibroid Embolization Device manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Uterine Fibroid Embolization Device Market Report

Report Metric Details
Report Name Uterine Fibroid Embolization Device Market
Segment by Type
  • Gelatin Sponge
  • Polyvinyl Alcohol ( PVA ) Particles
  • Trisacryl Gelatin Microspheres ( TAGM )
  • Polymethyl Methacrylate ( PMMA ) Microspheres
Segment by Application
  • Hospitals
  • Clinics
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boston Scientific Corporation, Merit Medical Systems, BioSpace, Hologic, Inc., Cook Medical, Ferring B.V., Smith+Nephew, CooperSurgical, Inc., Aetna Better Health of Pennsylvania, Ethicon US, LLC, Olympus America, Stryker, Astellas Pharma, Nippon Kayaku, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Uterine Fibroid Embolization Device manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Uterine Fibroid Embolization Device in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Uterine Fibroid Embolization Device Market report?

Ans: The main players in the Uterine Fibroid Embolization Device Market are Boston Scientific Corporation, Merit Medical Systems, BioSpace, Hologic, Inc., Cook Medical, Ferring B.V., Smith+Nephew, CooperSurgical, Inc., Aetna Better Health of Pennsylvania, Ethicon US, LLC, Olympus America, Stryker, Astellas Pharma, Nippon Kayaku, Pfizer

What are the Application segmentation covered in the Uterine Fibroid Embolization Device Market report?

Ans: The Applications covered in the Uterine Fibroid Embolization Device Market report are Hospitals, Clinics

What are the Type segmentation covered in the Uterine Fibroid Embolization Device Market report?

Ans: The Types covered in the Uterine Fibroid Embolization Device Market report are Gelatin Sponge, Polyvinyl Alcohol ( PVA ) Particles, Trisacryl Gelatin Microspheres ( TAGM ), Polymethyl Methacrylate ( PMMA ) Microspheres

1 Uterine Fibroid Embolization Device Market Overview
1.1 Product Overview and Scope of Uterine Fibroid Embolization Device
1.2 Uterine Fibroid Embolization Device Segment by Type
1.2.1 Global Uterine Fibroid Embolization Device Market Value Comparison by Type (2024-2030)
1.2.2 Gelatin Sponge
1.2.3 Polyvinyl Alcohol ( PVA ) Particles
1.2.4 Trisacryl Gelatin Microspheres ( TAGM )
1.2.5 Polymethyl Methacrylate ( PMMA ) Microspheres
1.3 Uterine Fibroid Embolization Device Segment by Application
1.3.1 Global Uterine Fibroid Embolization Device Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Uterine Fibroid Embolization Device Market Size Estimates and Forecasts
1.4.1 Global Uterine Fibroid Embolization Device Revenue 2019-2030
1.4.2 Global Uterine Fibroid Embolization Device Sales 2019-2030
1.4.3 Global Uterine Fibroid Embolization Device Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Uterine Fibroid Embolization Device Market Competition by Manufacturers
2.1 Global Uterine Fibroid Embolization Device Sales Market Share by Manufacturers (2019-2024)
2.2 Global Uterine Fibroid Embolization Device Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Uterine Fibroid Embolization Device Average Price by Manufacturers (2019-2024)
2.4 Global Uterine Fibroid Embolization Device Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Uterine Fibroid Embolization Device, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Uterine Fibroid Embolization Device, Product Type & Application
2.7 Uterine Fibroid Embolization Device Market Competitive Situation and Trends
2.7.1 Uterine Fibroid Embolization Device Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Uterine Fibroid Embolization Device Players Market Share by Revenue
2.7.3 Global Uterine Fibroid Embolization Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Uterine Fibroid Embolization Device Retrospective Market Scenario by Region
3.1 Global Uterine Fibroid Embolization Device Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Uterine Fibroid Embolization Device Global Uterine Fibroid Embolization Device Sales by Region: 2019-2030
3.2.1 Global Uterine Fibroid Embolization Device Sales by Region: 2019-2024
3.2.2 Global Uterine Fibroid Embolization Device Sales by Region: 2025-2030
3.3 Global Uterine Fibroid Embolization Device Global Uterine Fibroid Embolization Device Revenue by Region: 2019-2030
3.3.1 Global Uterine Fibroid Embolization Device Revenue by Region: 2019-2024
3.3.2 Global Uterine Fibroid Embolization Device Revenue by Region: 2025-2030
3.4 North America Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.4.1 North America Uterine Fibroid Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Uterine Fibroid Embolization Device Sales by Country (2019-2030)
3.4.3 North America Uterine Fibroid Embolization Device Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.5.1 Europe Uterine Fibroid Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Uterine Fibroid Embolization Device Sales by Country (2019-2030)
3.5.3 Europe Uterine Fibroid Embolization Device Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.6.1 Asia Pacific Uterine Fibroid Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Uterine Fibroid Embolization Device Sales by Country (2019-2030)
3.6.3 Asia Pacific Uterine Fibroid Embolization Device Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.7.1 Latin America Uterine Fibroid Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Uterine Fibroid Embolization Device Sales by Country (2019-2030)
3.7.3 Latin America Uterine Fibroid Embolization Device Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Uterine Fibroid Embolization Device Market Facts & Figures by Country
3.8.1 Middle East and Africa Uterine Fibroid Embolization Device Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Uterine Fibroid Embolization Device Sales by Country (2019-2030)
3.8.3 Middle East and Africa Uterine Fibroid Embolization Device Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Uterine Fibroid Embolization Device Sales by Type (2019-2030)
4.1.1 Global Uterine Fibroid Embolization Device Sales by Type (2019-2024)
4.1.2 Global Uterine Fibroid Embolization Device Sales by Type (2025-2030)
4.1.3 Global Uterine Fibroid Embolization Device Sales Market Share by Type (2019-2030)
4.2 Global Uterine Fibroid Embolization Device Revenue by Type (2019-2030)
4.2.1 Global Uterine Fibroid Embolization Device Revenue by Type (2019-2024)
4.2.2 Global Uterine Fibroid Embolization Device Revenue by Type (2025-2030)
4.2.3 Global Uterine Fibroid Embolization Device Revenue Market Share by Type (2019-2030)
4.3 Global Uterine Fibroid Embolization Device Price by Type (2019-2030)
5 Segment by Application
5.1 Global Uterine Fibroid Embolization Device Sales by Application (2019-2030)
5.1.1 Global Uterine Fibroid Embolization Device Sales by Application (2019-2024)
5.1.2 Global Uterine Fibroid Embolization Device Sales by Application (2025-2030)
5.1.3 Global Uterine Fibroid Embolization Device Sales Market Share by Application (2019-2030)
5.2 Global Uterine Fibroid Embolization Device Revenue by Application (2019-2030)
5.2.1 Global Uterine Fibroid Embolization Device Revenue by Application (2019-2024)
5.2.2 Global Uterine Fibroid Embolization Device Revenue by Application (2025-2030)
5.2.3 Global Uterine Fibroid Embolization Device Revenue Market Share by Application (2019-2030)
5.3 Global Uterine Fibroid Embolization Device Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Boston Scientific Corporation
6.1.1 Boston Scientific Corporation Corporation Information
6.1.2 Boston Scientific Corporation Description and Business Overview
6.1.3 Boston Scientific Corporation Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Boston Scientific Corporation Uterine Fibroid Embolization Device Product Portfolio
6.1.5 Boston Scientific Corporation Recent Developments/Updates
6.2 Merit Medical Systems
6.2.1 Merit Medical Systems Corporation Information
6.2.2 Merit Medical Systems Description and Business Overview
6.2.3 Merit Medical Systems Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merit Medical Systems Uterine Fibroid Embolization Device Product Portfolio
6.2.5 Merit Medical Systems Recent Developments/Updates
6.3 BioSpace
6.3.1 BioSpace Corporation Information
6.3.2 BioSpace Description and Business Overview
6.3.3 BioSpace Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.3.4 BioSpace Uterine Fibroid Embolization Device Product Portfolio
6.3.5 BioSpace Recent Developments/Updates
6.4 Hologic, Inc.
6.4.1 Hologic, Inc. Corporation Information
6.4.2 Hologic, Inc. Description and Business Overview
6.4.3 Hologic, Inc. Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hologic, Inc. Uterine Fibroid Embolization Device Product Portfolio
6.4.5 Hologic, Inc. Recent Developments/Updates
6.5 Cook Medical
6.5.1 Cook Medical Corporation Information
6.5.2 Cook Medical Description and Business Overview
6.5.3 Cook Medical Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cook Medical Uterine Fibroid Embolization Device Product Portfolio
6.5.5 Cook Medical Recent Developments/Updates
6.6 Ferring B.V.
6.6.1 Ferring B.V. Corporation Information
6.6.2 Ferring B.V. Description and Business Overview
6.6.3 Ferring B.V. Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Ferring B.V. Uterine Fibroid Embolization Device Product Portfolio
6.6.5 Ferring B.V. Recent Developments/Updates
6.7 Smith+Nephew
6.6.1 Smith+Nephew Corporation Information
6.6.2 Smith+Nephew Description and Business Overview
6.6.3 Smith+Nephew Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Smith+Nephew Uterine Fibroid Embolization Device Product Portfolio
6.7.5 Smith+Nephew Recent Developments/Updates
6.8 CooperSurgical, Inc.
6.8.1 CooperSurgical, Inc. Corporation Information
6.8.2 CooperSurgical, Inc. Description and Business Overview
6.8.3 CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.8.4 CooperSurgical, Inc. Uterine Fibroid Embolization Device Product Portfolio
6.8.5 CooperSurgical, Inc. Recent Developments/Updates
6.9 Aetna Better Health of Pennsylvania
6.9.1 Aetna Better Health of Pennsylvania Corporation Information
6.9.2 Aetna Better Health of Pennsylvania Description and Business Overview
6.9.3 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product Portfolio
6.9.5 Aetna Better Health of Pennsylvania Recent Developments/Updates
6.10 Ethicon US, LLC
6.10.1 Ethicon US, LLC Corporation Information
6.10.2 Ethicon US, LLC Description and Business Overview
6.10.3 Ethicon US, LLC Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Ethicon US, LLC Uterine Fibroid Embolization Device Product Portfolio
6.10.5 Ethicon US, LLC Recent Developments/Updates
6.11 Olympus America
6.11.1 Olympus America Corporation Information
6.11.2 Olympus America Uterine Fibroid Embolization Device Description and Business Overview
6.11.3 Olympus America Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Olympus America Uterine Fibroid Embolization Device Product Portfolio
6.11.5 Olympus America Recent Developments/Updates
6.12 Stryker
6.12.1 Stryker Corporation Information
6.12.2 Stryker Uterine Fibroid Embolization Device Description and Business Overview
6.12.3 Stryker Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Stryker Uterine Fibroid Embolization Device Product Portfolio
6.12.5 Stryker Recent Developments/Updates
6.13 Astellas Pharma
6.13.1 Astellas Pharma Corporation Information
6.13.2 Astellas Pharma Uterine Fibroid Embolization Device Description and Business Overview
6.13.3 Astellas Pharma Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Astellas Pharma Uterine Fibroid Embolization Device Product Portfolio
6.13.5 Astellas Pharma Recent Developments/Updates
6.14 Nippon Kayaku
6.14.1 Nippon Kayaku Corporation Information
6.14.2 Nippon Kayaku Uterine Fibroid Embolization Device Description and Business Overview
6.14.3 Nippon Kayaku Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Nippon Kayaku Uterine Fibroid Embolization Device Product Portfolio
6.14.5 Nippon Kayaku Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Corporation Information
6.15.2 Pfizer Uterine Fibroid Embolization Device Description and Business Overview
6.15.3 Pfizer Uterine Fibroid Embolization Device Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Pfizer Uterine Fibroid Embolization Device Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Uterine Fibroid Embolization Device Industry Chain Analysis
7.2 Uterine Fibroid Embolization Device Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Uterine Fibroid Embolization Device Production Mode & Process
7.4 Uterine Fibroid Embolization Device Sales and Marketing
7.4.1 Uterine Fibroid Embolization Device Sales Channels
7.4.2 Uterine Fibroid Embolization Device Distributors
7.5 Uterine Fibroid Embolization Device Customers
8 Uterine Fibroid Embolization Device Market Dynamics
8.1 Uterine Fibroid Embolization Device Industry Trends
8.2 Uterine Fibroid Embolization Device Market Drivers
8.3 Uterine Fibroid Embolization Device Market Challenges
8.4 Uterine Fibroid Embolization Device Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Uterine Fibroid Embolization Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Uterine Fibroid Embolization Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Uterine Fibroid Embolization Device Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Uterine Fibroid Embolization Device Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Uterine Fibroid Embolization Device Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Uterine Fibroid Embolization Device Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Uterine Fibroid Embolization Device Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Uterine Fibroid Embolization Device Average Price (US$/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Uterine Fibroid Embolization Device, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Uterine Fibroid Embolization Device, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Uterine Fibroid Embolization Device, Product Type & Application
    Table 12. Global Key Manufacturers of Uterine Fibroid Embolization Device, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Uterine Fibroid Embolization Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Uterine Fibroid Embolization Device as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Uterine Fibroid Embolization Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Uterine Fibroid Embolization Device Sales by Region (2019-2024) & (K Units)
    Table 18. Global Uterine Fibroid Embolization Device Sales Market Share by Region (2019-2024)
    Table 19. Global Uterine Fibroid Embolization Device Sales by Region (2025-2030) & (K Units)
    Table 20. Global Uterine Fibroid Embolization Device Sales Market Share by Region (2025-2030)
    Table 21. Global Uterine Fibroid Embolization Device Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Uterine Fibroid Embolization Device Revenue Market Share by Region (2019-2024)
    Table 23. Global Uterine Fibroid Embolization Device Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Uterine Fibroid Embolization Device Revenue Market Share by Region (2025-2030)
    Table 25. North America Uterine Fibroid Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Uterine Fibroid Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 27. North America Uterine Fibroid Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 28. North America Uterine Fibroid Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Uterine Fibroid Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Uterine Fibroid Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Uterine Fibroid Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Uterine Fibroid Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Uterine Fibroid Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Uterine Fibroid Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Uterine Fibroid Embolization Device Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Uterine Fibroid Embolization Device Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Uterine Fibroid Embolization Device Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Uterine Fibroid Embolization Device Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Uterine Fibroid Embolization Device Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Uterine Fibroid Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Uterine Fibroid Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Uterine Fibroid Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Uterine Fibroid Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Uterine Fibroid Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Uterine Fibroid Embolization Device Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Uterine Fibroid Embolization Device Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Uterine Fibroid Embolization Device Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Uterine Fibroid Embolization Device Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Uterine Fibroid Embolization Device Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Uterine Fibroid Embolization Device Sales (K Units) by Type (2019-2024)
    Table 51. Global Uterine Fibroid Embolization Device Sales (K Units) by Type (2025-2030)
    Table 52. Global Uterine Fibroid Embolization Device Sales Market Share by Type (2019-2024)
    Table 53. Global Uterine Fibroid Embolization Device Sales Market Share by Type (2025-2030)
    Table 54. Global Uterine Fibroid Embolization Device Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Uterine Fibroid Embolization Device Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Uterine Fibroid Embolization Device Revenue Market Share by Type (2019-2024)
    Table 57. Global Uterine Fibroid Embolization Device Revenue Market Share by Type (2025-2030)
    Table 58. Global Uterine Fibroid Embolization Device Price (US$/Unit) by Type (2019-2024)
    Table 59. Global Uterine Fibroid Embolization Device Price (US$/Unit) by Type (2025-2030)
    Table 60. Global Uterine Fibroid Embolization Device Sales (K Units) by Application (2019-2024)
    Table 61. Global Uterine Fibroid Embolization Device Sales (K Units) by Application (2025-2030)
    Table 62. Global Uterine Fibroid Embolization Device Sales Market Share by Application (2019-2024)
    Table 63. Global Uterine Fibroid Embolization Device Sales Market Share by Application (2025-2030)
    Table 64. Global Uterine Fibroid Embolization Device Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Uterine Fibroid Embolization Device Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Uterine Fibroid Embolization Device Revenue Market Share by Application (2019-2024)
    Table 67. Global Uterine Fibroid Embolization Device Revenue Market Share by Application (2025-2030)
    Table 68. Global Uterine Fibroid Embolization Device Price (US$/Unit) by Application (2019-2024)
    Table 69. Global Uterine Fibroid Embolization Device Price (US$/Unit) by Application (2025-2030)
    Table 70. Boston Scientific Corporation Corporation Information
    Table 71. Boston Scientific Corporation Description and Business Overview
    Table 72. Boston Scientific Corporation Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 73. Boston Scientific Corporation Uterine Fibroid Embolization Device Product
    Table 74. Boston Scientific Corporation Recent Developments/Updates
    Table 75. Merit Medical Systems Corporation Information
    Table 76. Merit Medical Systems Description and Business Overview
    Table 77. Merit Medical Systems Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 78. Merit Medical Systems Uterine Fibroid Embolization Device Product
    Table 79. Merit Medical Systems Recent Developments/Updates
    Table 80. BioSpace Corporation Information
    Table 81. BioSpace Description and Business Overview
    Table 82. BioSpace Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 83. BioSpace Uterine Fibroid Embolization Device Product
    Table 84. BioSpace Recent Developments/Updates
    Table 85. Hologic, Inc. Corporation Information
    Table 86. Hologic, Inc. Description and Business Overview
    Table 87. Hologic, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 88. Hologic, Inc. Uterine Fibroid Embolization Device Product
    Table 89. Hologic, Inc. Recent Developments/Updates
    Table 90. Cook Medical Corporation Information
    Table 91. Cook Medical Description and Business Overview
    Table 92. Cook Medical Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 93. Cook Medical Uterine Fibroid Embolization Device Product
    Table 94. Cook Medical Recent Developments/Updates
    Table 95. Ferring B.V. Corporation Information
    Table 96. Ferring B.V. Description and Business Overview
    Table 97. Ferring B.V. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 98. Ferring B.V. Uterine Fibroid Embolization Device Product
    Table 99. Ferring B.V. Recent Developments/Updates
    Table 100. Smith+Nephew Corporation Information
    Table 101. Smith+Nephew Description and Business Overview
    Table 102. Smith+Nephew Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 103. Smith+Nephew Uterine Fibroid Embolization Device Product
    Table 104. Smith+Nephew Recent Developments/Updates
    Table 105. CooperSurgical, Inc. Corporation Information
    Table 106. CooperSurgical, Inc. Description and Business Overview
    Table 107. CooperSurgical, Inc. Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 108. CooperSurgical, Inc. Uterine Fibroid Embolization Device Product
    Table 109. CooperSurgical, Inc. Recent Developments/Updates
    Table 110. Aetna Better Health of Pennsylvania Corporation Information
    Table 111. Aetna Better Health of Pennsylvania Description and Business Overview
    Table 112. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 113. Aetna Better Health of Pennsylvania Uterine Fibroid Embolization Device Product
    Table 114. Aetna Better Health of Pennsylvania Recent Developments/Updates
    Table 115. Ethicon US, LLC Corporation Information
    Table 116. Ethicon US, LLC Description and Business Overview
    Table 117. Ethicon US, LLC Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 118. Ethicon US, LLC Uterine Fibroid Embolization Device Product
    Table 119. Ethicon US, LLC Recent Developments/Updates
    Table 120. Olympus America Corporation Information
    Table 121. Olympus America Description and Business Overview
    Table 122. Olympus America Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 123. Olympus America Uterine Fibroid Embolization Device Product
    Table 124. Olympus America Recent Developments/Updates
    Table 125. Stryker Corporation Information
    Table 126. Stryker Description and Business Overview
    Table 127. Stryker Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 128. Stryker Uterine Fibroid Embolization Device Product
    Table 129. Stryker Recent Developments/Updates
    Table 130. Astellas Pharma Corporation Information
    Table 131. Astellas Pharma Description and Business Overview
    Table 132. Astellas Pharma Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 133. Astellas Pharma Uterine Fibroid Embolization Device Product
    Table 134. Astellas Pharma Recent Developments/Updates
    Table 135. Nippon Kayaku Corporation Information
    Table 136. Nippon Kayaku Description and Business Overview
    Table 137. Nippon Kayaku Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 138. Nippon Kayaku Uterine Fibroid Embolization Device Product
    Table 139. Nippon Kayaku Recent Developments/Updates
    Table 140. Pfizer Corporation Information
    Table 141. Pfizer Description and Business Overview
    Table 142. Pfizer Uterine Fibroid Embolization Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 143. Pfizer Uterine Fibroid Embolization Device Product
    Table 144. Pfizer Recent Developments/Updates
    Table 145. Key Raw Materials Lists
    Table 146. Raw Materials Key Suppliers Lists
    Table 147. Uterine Fibroid Embolization Device Distributors List
    Table 148. Uterine Fibroid Embolization Device Customers List
    Table 149. Uterine Fibroid Embolization Device Market Trends
    Table 150. Uterine Fibroid Embolization Device Market Drivers
    Table 151. Uterine Fibroid Embolization Device Market Challenges
    Table 152. Uterine Fibroid Embolization Device Market Restraints
    Table 153. Research Programs/Design for This Report
    Table 154. Key Data Information from Secondary Sources
    Table 155. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Uterine Fibroid Embolization Device
    Figure 2. Global Uterine Fibroid Embolization Device Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Uterine Fibroid Embolization Device Market Share by Type in 2023 & 2030
    Figure 4. Gelatin Sponge Product Picture
    Figure 5. Polyvinyl Alcohol ( PVA ) Particles Product Picture
    Figure 6. Trisacryl Gelatin Microspheres ( TAGM ) Product Picture
    Figure 7. Polymethyl Methacrylate ( PMMA ) Microspheres Product Picture
    Figure 8. Global Uterine Fibroid Embolization Device Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Uterine Fibroid Embolization Device Market Share by Application in 2023 & 2030
    Figure 10. Hospitals
    Figure 11. Clinics
    Figure 12. Global Uterine Fibroid Embolization Device Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Uterine Fibroid Embolization Device Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Uterine Fibroid Embolization Device Sales (2019-2030) & (K Units)
    Figure 15. Global Uterine Fibroid Embolization Device Average Price (US$/Unit) & (2019-2030)
    Figure 16. Uterine Fibroid Embolization Device Report Years Considered
    Figure 17. Uterine Fibroid Embolization Device Sales Share by Manufacturers in 2023
    Figure 18. Global Uterine Fibroid Embolization Device Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Uterine Fibroid Embolization Device Players: Market Share by Revenue in 2023
    Figure 20. Uterine Fibroid Embolization Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Uterine Fibroid Embolization Device Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Uterine Fibroid Embolization Device Sales Market Share by Country (2019-2030)
    Figure 23. North America Uterine Fibroid Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 24. United States Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Uterine Fibroid Embolization Device Sales Market Share by Country (2019-2030)
    Figure 27. Europe Uterine Fibroid Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Uterine Fibroid Embolization Device Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Uterine Fibroid Embolization Device Revenue Market Share by Region (2019-2030)
    Figure 35. China Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Uterine Fibroid Embolization Device Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Uterine Fibroid Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Uterine Fibroid Embolization Device Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Uterine Fibroid Embolization Device Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Uterine Fibroid Embolization Device Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Uterine Fibroid Embolization Device by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Uterine Fibroid Embolization Device by Type (2019-2030)
    Figure 56. Global Uterine Fibroid Embolization Device Price (US$/Unit) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Uterine Fibroid Embolization Device by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Uterine Fibroid Embolization Device by Application (2019-2030)
    Figure 59. Global Uterine Fibroid Embolization Device Price (US$/Unit) by Application (2019-2030)
    Figure 60. Uterine Fibroid Embolization Device Value Chain
    Figure 61. Uterine Fibroid Embolization Device Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network